| 2025 | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 141,7 k € | +15.0% | 123,2 k € | -62.5% | 328,4 k € | +193.0% | 112,1 k € | +47.5% | 76,0 k € | +79.1% | 42,4 k € | -33.8% | 64,1 k € | +3.8% | 61,7 k € | +10.9% | 55,6 k € | -2.8% | 57,2 k € | +11.3% | 51,4 k € | +12.1% | 45,9 k € | -13.6% | 53,1 k € | +13.5% | 46,8 k € | +18.5% | 39,5 k € | -10.5% | 44,1 k € | |
| EBITDA | 138,3 k € | +24.3% | 111,3 k € | -65.8% | 325,5 k € | +197.4% | 109,4 k € | +48.9% | 73,5 k € | +53.9% | 47,7 k € | -24.3% | 63,1 k € | +22.8% | 51,4 k € | -3.3% | 53,1 k € | -0.6% | 53,5 k € | +6.5% | 50,2 k € | +14.7% | 43,8 k € | -14.2% | 51,0 k € | +14.7% | 44,5 k € | +18.0% | 37,7 k € | -10.8% | 42,3 k € | |
| Operating profit | 125,4 k € | +27.4% | 98,5 k € | -69.2% | 319,8 k € | +254.3% | 90,2 k € | +82.0% | 49,6 k € | +209.0% | 16,1 k € | -55.1% | 35,8 k € | +47.4% | 24,3 k € | -5.5% | 25,7 k € | +1.9% | 25,2 k € | -2.3% | 25,8 k € | +40.3% | 18,4 k € | -24.3% | 24,3 k € | +116.3% | 11,2 k € | -36.6% | 17,7 k € | -7.1% | 19,1 k € | |
| Profit/loss | 88,9 k € | +25.8% | 70,6 k € | -67.6% | 217,7 k € | +258.3% | 60,8 k € | +117.1% | 28,0 k € | +166.7% | 10,5 k € | -54.0% | 22,8 k € | +95.0% | 11,7 k € | -21.2% | 14,8 k € | -0.4% | 14,9 k € | +27.2% | 11,7 k € | +53.0% | 7,7 k € | -4.8% | 8,1 k € | +463.7% | 1,4 k € | -74.7% | 5,7 k € | +58.8% | 3,6 k € | |
| Equity | 520,0 k € | +14.4% | 454,3 k € | +9.7% | 414,1 k € | +84.5% | 224,4 k € | +250.3% | 64,1 k € | -18.8% | 78,9 k € | -38.5% | 128,5 k € | +21.6% | 105,6 k € | +12.5% | 93,9 k € | +18.8% | 79,1 k € | +6.6% | 74,2 k € | +8.4% | 68,5 k € | +12.6% | 60,8 k € | +15.3% | 52,8 k € | +2.8% | 51,3 k € | +12.4% | 45,7 k € | |
| Total assets | 529,0 k € | +14.7% | 461,3 k € | +6.3% | 434,1 k € | +75.5% | 247,4 k € | +93.3% | 128,0 k € | -27.2% | 175,9 k € | -12.9% | 201,8 k € | -7.4% | 217,9 k € | -4.3% | 227,8 k € | -8.9% | 249,9 k € | +5.0% | 238,0 k € | -9.0% | 261,5 k € | -7.9% | 283,8 k € | -17.6% | 344,5 k € | +44.7% | 238,1 k € | -3.1% | 245,9 k € | |
| Cash | 283,2 k € | +92.1% | 147,4 k € | +13.2% | 130,3 k € | -39.4% | 214,9 k € | +781.3% | 24,4 k € | +105.7% | 11,9 k € | +104.6% | 5,8 k € | +44.3% | 4,0 k € | +3685.5% | 106,1 € | -97.5% | 4,2 k € | +46.6% | 2,9 k € | -21.1% | 3,6 k € | -24.8% | 4,8 k € | -92.5% | 64,4 k € | +85592.7% | 75,1 € | -97.7% | 3,3 k € | |
| Debts | 7,0 k € | +78.7% | 3,9 k € | -73.8% | 14,9 k € | -17.1% | 17,9 k € | -69.5% | 58,9 k € | -35.9% | 91,9 k € | +49.8% | 61,4 k € | -38.8% | 100,3 k € | -22.1% | 128,8 k € | -23.5% | 168,3 k € | +4.7% | 160,7 k € | -15.2% | 189,4 k € | -13.7% | 219,6 k € | -23.5% | 287,1 k € | +57.4% | 182,4 k € | -7.0% | 196,1 k € | |
Source: Belgian Official Gazette
Private limited company · Evergem · incorporated on 30/03/1998
Private limited company profitable and well capitalised. Cash position rising (+92.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr Natasja Keereman is a Private limited company incorporated in 1998. Its main activity is: General medical practice activities. Its registered office is in Evergem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.